Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Abeona Therapeutics (ABEO) over the last 6 years, with Q3 2025 value amounting to $5000.0.

  • Abeona Therapeutics' Non-cash Items fell 3750.0% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5000.0, marking a year-over-year decrease of 3750.0%. This contributed to the annual value of $163386.0 for FY2024, which is 2078.42% up from last year.
  • Latest data reveals that Abeona Therapeutics reported Non-cash Items of $5000.0 as of Q3 2025, which was down 3750.0% from $172830.0 recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Non-cash Items high stood at $172830.0 for Q2 2025, and its period low was $1000.0 during Q2 2024.
  • Its 3-year average for Non-cash Items is $62515.4, with a median of $6500.0 in 2024.
  • Over the last 5 years, Abeona Therapeutics' Non-cash Items had its largest YoY gain of 1718300.0% in 2025, and its largest YoY loss of 9791.53% in 2025.
  • Quarter analysis of 3 years shows Abeona Therapeutics' Non-cash Items stood at $3000.0 in 2023, then skyrocketed by 5346.2% to $163386.0 in 2024, then tumbled by 96.94% to $5000.0 in 2025.
  • Its last three reported values are $5000.0 in Q3 2025, $172830.0 for Q2 2025, and $3000.0 during Q1 2025.